Literature DB >> 20146992

Influence of significant weight loss on serum matrix metalloproteinase (MMP)-7 levels.

Claudia Ress1, Alexander Tschoner, Christian Ciardi, Markus W Laimer, Julia W Engl, Wolfgang Sturm, Helmut Weiss, Herbert Tilg, Christoph F Ebenbichler, Josef R Patsch, Susanne Kaser.   

Abstract

BACKGROUND: Matrix metalloproteinases (MMPs) and their specific inhibitors (tissue inhibitor of metalloproteinases [TIMPs]), are involved in adipogenesis, angiogenesis and remodeling of extracellular matrix. MMPs and TIMPs have been shown to be associated with various diseases such as neurological disorders, malignancies and cardiovascular disease. MMPs and TIMPs are thought to play a major role in extensive reorganization of the adipose tissue in obesity. METHODS AND MATERIALS: To test whether significant weight loss alters circulating MMPs and TIMPs, 18 morbidly obese women, who underwent bariatric surgery for weight loss, were investigated before and one year after surgery in a prospective design study. Body composition, glucose and lipid metabolism parameters were determined in all study subjects before and after weight loss. Circulating MMP-2, -3, -7 and TIMP-1, -2 and -4 serum levels were measured using commercially available, enzyme-linked immunoassays.
RESULTS: Pronounced weight loss was accompanied by improvements in glucose homeostasis and lipid parameters. In the mean time MMP-2 and MMP-3, as well as TIMP-1, -2 and TIMP-4 concentrations were not affected by significant weight loss, and circulating MMP-7 increased significantly after bariatric surgery, although without reaching the standard levels as determined in 18, lean, healthy women.
CONCLUSION: Our data indicate that reduced MMP-7 levels in obesity might be restored by significant weight loss, suggesting that the reorganization of adipose tissue in obesity might be partially reversible by weight reduction. We hypothesize that increased circulating MMP-7 might indicate enhanced adipocyte differentiation in subjects who had undergone bariatric surgery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146992     DOI: 10.1684/ecn.2009.0177

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  16 in total

1.  Diabetes Associated Markers After Bariatric Surgery: Fetuin-A, but Not Matrix Metalloproteinase-7, Is Reduced.

Authors:  Po-Jen Yang; Kong-Han Ser; Ming-Tsan Lin; Hsiao-Ching Nien; Chiung-Nien Chen; Wei-Shiung Yang; Wei-Jei Lee
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

2.  M1 Polarized Macrophages Persist in Skin of Post-Bariatric Patients after 2 Years.

Authors:  Carlo Amaral; Juliana Rodrigues da Costa; Matheus Oliveira Costa; João Paulo Verbicario; Leonardo Dias; Natale F Gontijo-de-Amorim; Luiz Charles-de-Sá; Christina Maeda Takiya
Journal:  Aesthetic Plast Surg       Date:  2021-11-08       Impact factor: 2.326

3.  Serum SPARC and matrix metalloproteinase-2 and metalloproteinase-9 concentrations after bariatric surgery in obese adults.

Authors:  Yeon Ji Lee; Yoon-Seok Heo; Hye Soon Park; Seoung Hee Lee; Seul Ki Lee; Yeon Jin Jang
Journal:  Obes Surg       Date:  2014-04       Impact factor: 4.129

4.  Start of insulin therapy in patients with type 2 diabetes mellitus promotes the influx of macrophages into subcutaneous adipose tissue.

Authors:  H J Jansen; R Stienstra; J A van Diepen; A Hijmans; J A van der Laak; G M M Vervoort; C J Tack
Journal:  Diabetologia       Date:  2013-09-25       Impact factor: 10.122

5.  Contributions of adipose tissue architectural and tensile properties toward defining healthy and unhealthy obesity.

Authors:  Denise E Lackey; David H Burk; Mohamed R Ali; Rouzbeh Mostaedi; William H Smith; Jiyoung Park; Philipp E Scherer; Shundra A Seay; Colin S McCoin; Paolo Bonaldo; Sean H Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-03       Impact factor: 4.310

Review 6.  How Does Fat Mass Change in the First Year After Bariatric Surgery? A Systemic Review and Meta-Analysis.

Authors:  Neda Haghighat; Damoon Ashtari-Larky; Ladan Aghakhani; Omid Asbaghi; Hamidreza Hoseinpour; Babak Hosseini; Ali Shahabinezhad; Arash Pourmohammad; Seyed Vahid Hosseini; Masoud Amini; Cain C T Clark; Alimohammad Bananzadeh
Journal:  Obes Surg       Date:  2021-06-05       Impact factor: 4.129

7.  Proof of Concept: Matrix metalloproteinase inhibitor decreases inflammation and improves muscle insulin sensitivity in people with type 2 diabetes.

Authors:  Karen Frankwich; Courtney Tibble; Moises Torres-Gonzalez; Mariah Bonner; Roy Lefkowitz; Matt Tyndall; Geert W Schmid-Schönbein; Francisco Villarreal; Mike Heller; Karen Herbst
Journal:  J Inflamm (Lond)       Date:  2012-10-01       Impact factor: 4.981

Review 8.  Matrix Metalloproteinases in Non-Neoplastic Disorders.

Authors:  Akinori Tokito; Michihisa Jougasaki
Journal:  Int J Mol Sci       Date:  2016-07-21       Impact factor: 5.923

9.  Chardonnay Grape Seed Flour Ameliorates Hepatic Steatosis and Insulin Resistance via Altered Hepatic Gene Expression for Oxidative Stress, Inflammation, and Lipid and Ceramide Synthesis in Diet-Induced Obese Mice.

Authors:  Kun-Ho Seo; Glenn E Bartley; Christina Tam; Hong-Seok Kim; Dong-Hyeon Kim; Jung-Whan Chon; Hyunsook Kim; Wallace Yokoyama
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

10.  Differential proinflammatory and oxidative stress response and vulnerability to metabolic syndrome in habitual high-fat young male consumers putatively predisposed by their genetic background.

Authors:  Pedro González-Muniesa; María Pilar Marrades; José Alfredo Martínez; María Jesús Moreno-Aliaga
Journal:  Int J Mol Sci       Date:  2013-08-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.